Illustrative example – A monitor at the nurses’ station monitors a patient undergoing radiation therapy at Sheba Medical Center. (Photo: Chen Leopold/Flash90)
Belong.Life, an Israeli company specializing in artificial intelligence solutions for the healthcare sector, releases an innovative app designed to empower cancer patients by providing advanced support in managing their disease Did.
of BelongAI Dave app uses cutting-edge AI technology and is considered the most advanced AI tool of its kind, delivering services through 24/7 proactive mentoring.
Belong Life Co-founder and CEO Eliran Marchi said the cutting-edge app combines accessibility and affordability.
“Proximity to a hospital or the size of your bank account should not determine your priority in answering a patient’s questions and needs. The BelongAI Dave – Cancer Mentor app makes personalized cancer support accessible to everyone. , at an affordable price,” said Malki. explained.
Irad Deutsch, the company’s other co-founder, believes BelongAI Dave will revolutionize proactive support for cancer patients.
The app is connected to a huge repository containing over 2 million data points. The vast amount of data includes peer-to-peer exchanges and patient-doctor interactions within the BelongLife community. Access to such large amounts of data enables highly accurate and patient-specific medical support. AI technology enables continuous improvement by accumulating past data.
Cancer is a serious medical challenge, especially in many Western countries with aging populations. In 2020, International Cancer Research Fund It is estimated that there are approximately 18 million known cancer cases worldwide. Although cancer affects both genders, statistics show that it is slightly more common in men than in women.
Known for its advanced medical equipment and know-how, the Jewish state has made significant contributions to the medical field, including medical research and cancer treatment.
In March 2023, Israeli researchers pancreatic cancer treatment, one of the most deadly cancers in the world. Professor Rotem Karni of the Hebrew University of Medicine, who led the study, explained the importance of the study.
In June 2023, Israeli researchers from Sheba Medical Center and Tel Aviv University A breakthrough in the fight against deadly skin cancer. The Israel Cancer Research Fund supported this groundbreaking research. Professor Shoshana Greenberger from Sheba Medical Center outside Tel Aviv explained that the study focused on the relationship between melanoma and the formation of lymphatic vessels.
“Our main research question was how melanoma affects lymphatic vessel formation and metastasis through it,” Greenberger said. Said.
shiva hospital recently ranked It is rated the ninth best medical facility in the world by Newsweek magazine. Known for its highly qualified staff and use of cutting-edge technology, Sheba Hospital is ranked among the best hospitals in the Middle East, and last September, Newsweek magazine ranked Sheba Hospital among the best hospitals in the world. Top 20 major “smart hospitals”.
